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Nuclear Magnetic Resonance (NMR) Spectroscopy. 1H and 13C NMR 
spectra of molecules were recorded on a Varian 400 Unity plus (400 MHz) 
spectrometer in deuterated chloroform (or other given solvents) as internal 
reference. The Chemical shift δ was reported in ppm. The definition of splitting 
pattern was: s, singlet; d, doublet; t, triplet; q, quartet; qn, quintet; sex, sextet; m, 
multiplet. Coupling constant was represented by J and reported in Hz. 
Mass Spectrometry. Mass spectra were recorded using a Bruker timsTOF mass 
spectrometer and Bruker Daltonics autoflex speed with electrospray ionization 
(ESI) and matrix-assisted laser desorption/ionization (MALDI) as the ionization 
method.  
Thermogravimetric analysis (TGA). Decomposed temperature (Td, 5% weight 
loss) were measured with a Dynamic Q500 Thermo-Gravimetric Analyzer under a 
nitrogen atmosphere with heating and cooling rates of 10 °C·min-1. 
Differential Scanning Calorimetry (DSC). The melting and crystallization 
temperatures were measured using Perkin Elmer Jade DSC 4000 under nitrogen flow 
with heating and cooling rates of 10 °C·min-1. 
UV-Vis Absorption Measurement. The absorption spectra of in CH2Cl2 solutions 
(1 – 10 μM) were measured by spectrophotometers JASCO V-670 spectrophotometer. 
Electrochemical Characterization. The electrochemical properties of molecules 
were investigated by cyclic voltammetry (CV). The measurement of oxidation 
potentials was carried out in anhydrous CH2Cl2 solution (1.0 mM) containing 0.1 M 
tetrabutylammonium hexafluorophosphate (TBAPF6) as a supporting electrolyte, while 
the measurement of the reduction potentials were conducted in an anhydrous THF 
solution (1.0 mM) containing 0.1 M tetrabutylammonium perchlorate (TBAP)  as a 
supporting electrolyte, purged with argon prior to conduct the measurements. A glassy 
carbon electrode and a platinum wire was used as the working electrode and counter 
electrode, respectively. All potentials were recorded versus Ag/AgCl (saturated) as a 
reference electrode and calibrated with the ferrocene/ferrocenium (Fc/Fc+) redox 
couple. All measurements were performed at a scan rate of 100 mVs-1. 
Single Crystal Structure Determinations. Crystallographic data were collected 
at 295(2) K on an Oxford Gemini A CCD diffractometer using graphite-
monochromatized Cu-Kα radiation (λ = 1.54178 Å). Cell parameters were retrieved and 
refined using CrysAlis Pro software on all observed reflections. Data reduction was 
performed with the CrysAlis Pro software. The structures were solved and refined with 
SHELXL programs. The hydrogen atoms were included in calculated positions and 
refined using a riding mode. 
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OPV Device Fabrication. In this work, the D − A − A type donor materials were 
synthesized in the laboratory. Other materials, MoO3, C70, BCP, BPhen and Ag were 
purchased from commercially available resources. All organic materials had been 
sublimated twice by using our homemade graded purification system with a high 
vacuum of ∼ 8 × 10−6 torr. Before the device fabrication, the ITO substrate was 
sequentially soaked in solutions (acetone, isopropyl, and deionized water) and carried 
out in the ultrasonic vibration tank for 5 min followed by drying by nitrogen with 5N 
pressure. For OPV device preparation, the thin films were deposited by thermal 
evaporation under a high pressure of < 5 × 10−6 torr. The thickness of each layer was 
monitored by an in-situ quartz crystal monitor, which was calibrated by a surface 
profiler (Dektak XT). The size of anode and cathode pads defined our device’s active 
area of 4 mm2. After the device fabrication process, the devices were transferred into a 
nitrogen-filled glovebox with low oxygen and moisture (<0.1ppm). Then, all devices 
were appropriately encapsulated using UV-curable epoxy resin (Everwide Chemical 
Corporation Limited EXC345) and getter-attached cover glass to protect our OPV 
devices.  
OPV Device Measurement. The electrical characteristics of our OPV devices 
with 1 mm2 shadow mask were measured by a source meter (Keithley 2401) under a 
AAA solar simulator with the intensity of 100 mW cm-2 (Enli Tech, SS-X100R) and 
KG2 reference (Enli Tech, SRC-2020-KG2) which was calibrated by ISO/IEC 17025 
certified lab and traced to NREL. The spectral mismatch factor is 1.005 as according to 
IEC-60904-7 and NREL testing protocol. To confirm the repeatability, the data acquired 
from eight devices were utilized to give the averaged value and the standard deviation. 
The EQE spectrum was measured with a QE-R Solar Cell Spectral Response 
Measurement System (Enli Technology Co., Ltd., Taiwan). The reference spectrum 
(SS-X100R) of the solar simulator compared with the AM 1.5G solar spectrum is shown 
below.  
Indoor OPV measurement. For evaluating the electrical characteristics of indoor 
OPVs, the devices were measured using a commercial indoor PV measurement system 
(CMS-PV101) with a fluorescent lamp (PHILIPS TLD 18W/840) and Keithley 2401, 
which was designed by the Center for Measurement Standards, Industrial Technology 
Research Institute (ITRI, Taiwan). In this measurement system, the fluorescent lamp 
was mounted on the top of a designed room-liked construction space with normal 
incidence, the light intensity of the fluorescent lamp can be easily controlled from 0 to 
2500 lux by a programmed software, while the nonuniformity and temporal instability 
were kept < 2%. To check the irradiance and luminance qualities, the lux levels of the 
fluorescence lamps were measured using a lux meter (TES1332A DIGITAL LUX 
S-3 
METER) and the intensity calibration was carried out by using the spectrometer (BLUE 
– Wave UVNb-25 Spectrometer). The testing procedure of indoor OPV was followed
as described in the previous work11. The spectrum and intensity of the fluorescent lamp
(PHILIPS TLD 18W/840) at brightness of 500 and 1000 lux are shown below.
1  Chen, C. H.; Ting, H. C.; Li, Y. Z.; Lo, Y. C.; Sher, P. H.; Wang, J. K.; Chiu, T. L.; 
Lin, C. F.; Hsu, I. S.; Lee, J. H.; Liu, S. W.; Wong, K. T. ACS Appl. Mater. & 
Interfaces 2019, 11, 8337-8349. 
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Figure S1. (a) TGA and (b) DSC analyses of CPNT, DCPNT, CPNBT and DCPNBT. 
Figure S2. (a) The reference spectrum (SS-X100R) of the solar simulator compared 
with the AM 1.5G solar spectrum. (b) The spectral intensity of the fluorescent lamp 
(PHILIPS TLD 18W/840) based on 500 and 1000 lux. The dash line is the correlative 
integral intensity of the spectral. 
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Table S1. X-ray data and structure refinement parameters for CPNT, DCPNT, 
CPNBT and DCPNBT crystals. 


















with 0.5 C6H14) 
Formula weight 1216.67 711.07 525.05 576.72 
T /K 200(2) 150(2) 200(2) 200(2) 
Crystal system Triclinic Triclinic Triclinic Triclinic 
Wavelength / Å 0.71073 1.54178 1.54178 1.54178 
Space group P-1 P-1 P-1 P-1
a /Å 10.8991(3) 7.2000(9) 6.9061(2) 10.5064(2) 
b /Å 17.1289(8) 9.1357(9) 11.8760(3) 12.3880(3) 
c /Å 18.5608(7) 25.837(3) 15.5321(4) 13.5519(3) 
α /º 114.553(4) 82.973(9) 91.7206(8) 64.4687(7) 
β /º 91.159(3) 87.501(9) 95.8705(8) 76.3120(7) 
γ /º 104.132(3) 72.172(10) 95.4305(8) 70.6562(7) 
V /Å3 3027.2(2) 1605.7(3) 1260.51(6) 1492.58(6) 
Z 2 2 2 2 
ρc /g.cm–3 1.335 1.471 1.383 1.283 
μ /mm–1 0.342 4.114 2.340 1.230 
F (000) 1252 728 546 606 
Reflections 
collected 





5791 (0.0799) 5092 (0.0210) 3839 (0.0119) 
R1, wR2 [I>2σ(I)] 
0.0953, 
0.2471 
0.0993, 0.2361 0.0533, 0.1433 0.0464, 0.1254 
R1, wR2 [all data] 
0.1485, 
0.2854 
0.1752, 0.2988 0.0560, 0.1461 0.0478, 0.1266 
GooF on F2 1.173 1.122 1.056 1.072 
Largest diff. peak 
and hole/ e.Å-3 
1.715, -0.903 0.997, -0.926 0.658, -0.518 0.698, -0.381 
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Table S2. Structural data of CPNT, DCPNT, DTCPB, DTDCPB, CPNBT and 
DCPNBT crystals. 
 
a Bond	length	alternation	(BLA) = (C2 − C3) − ("#$"%)'("($"))
%
 
Synthesis of compound 4 
Hexyne (1.14 mL, 10 mmol) was added dropwise catecholborane (11.94 mL, 1 M 
in THF). After stirred and heated at reflux temperature under argon atmosphere for 1.5 
h, the reaction mixture was added additional catecholborane (3.81 mL, 1M in THF) and 
then continued stirring for 2 h. The resulting alkene intermediate was cooled to room 
temperature and directly used into next step. A mixture of alkene intermediate (10 
mmol), 1 (5 g, 12.4 mmol), Pd(PPh3)4 (431 mg, 0.37 mmol), and sodium carbonate (7.5 
g , 24 mmol) in anhydrous toluene (620 mL) and nitrogen-bubbled distilled water ( 37 
mL) was stirred and heated at reflux temperature under argon atmosphere for 12 h. After 
cooling to room temperature, the solvent was removed by rotary evaporation. The 
resulting mixture was extract with chloroform, washed with brine, dried over anhydrous 
MgSO4, filtered, and then concentrated under reduced pressure. The crude product was 
purified by column chromatography with CHCl3:hexanes = 1:4 (v/v) as eluent to yield 
6 as a yellow solid (1.17 g, 29%). 1H NMR (400 MHz, CD2Cl2) δ 9.08 (s, 1H), 8.69 (s, 
1H), 7.33 (dt, J = 14.6, 7.2 Hz, 1H), 7.06 (d, J = 16.1 Hz, 1H), 2.43 (q, J = 8.1 Hz, 2H), 
1.61 (m, 2H), 1.46 (dq, J = 14.3, 7.1 Hz, 2H), 0.98 (t, J = 7.3 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 153.41, 153.26, 152.53, 152.45, 139.32, 131.30, 129.76, 125.55, 125.44, 
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124.66, 122.40, 113.16, 33.65, 31.28, 22.42, 14.00; HRMS (m/z, ESI+) Calcd for 
C16H1379BrN4S2 403.9765, found 403.9760; Calcd for C16H1381BrN4S2 405.9745, found 
405.9739. 
Synthesis of intermediate 5 
Hexyne (1.38 mL, 12 mmol) was added dropwise catecholborane (12.00 mL, 1 M 
in THF). After stirred and heated at reflux temperature under argon atmosphere for 1.5 
h, the reaction mixture was added additional catecholborane (4.00 mL, 1M in THF) and 
then continued stirring for 2 h. The resulting alkene intermediate was cooled to room 
temperature and directly used into next step. A mixture of alkene intermediate (10 
mmol), 2 (3.44 g, 10 mmol), Pd(PPh3)4 (924 mg, 0.8 mmol), and sodium carbonate 
(3.18 g, 30 mmol) in anhydrous toluene (100 mL) and nitrogen-bubbled distilled water 
(13 mL) was stirred and heated at reflux temperature under argon atmosphere for 12 h. 
After cooling to room temperature, the solution was filtered and the solid were washed 
by 100 mL of ethylacetate. The filtrate was washed with brine, water and the organic 
layer was dried over anhydrous MgSO4, filtered, and then concentrated under reduced 
pressure. The crude product was purified by column chromatography with 
CH2Cl2:hexanes = 3:7 (v/v) as eluent to afford intermediate 5 and was used directly in 
the next step. 
Synthesis of compound 6 
A solution of 4 (1.27 g, 3.1 mmol) in anhydrous CH2Cl2 (400 mL) was stirred and 
bubbled with ozone at -78 oC for 30 min. The reaction mixture was added dimethyl 
sulfide (2 mL, 27 mmol) and then stirred at room temperature for 12 h. The resulting 
mixture was concentrated by rotary evaporation and purified by column 
chromatography with CHCl3 as eluent to yield 8 as a light yellow solid (0.83 g, 75%). 
1H NMR (400 MHz, CDCl3) δ 10.86 (s, 1H), 9.47 (s, 1H), 9.26 (s, 1H); 13C NMR 
spectra of 8 is not available due to the low solubility; HRMS (m/z, EI+) Calcd for 
C11H379BrN4OS2 349.8932, found 349.8935; Calcd for C11H381BrN4OS2 351.8911, 
found 351.8913. 
Synthesis of compound 7 
The intermediate 5 from the previous step was dissolved in anhydrous CH2Cl2 (100 mL) 
and was stirred and bubbled with ozone at -78 oC for 20 min. The reaction mixture was 
added dimethyl sulfide (7 mL, 100 mmol) and then stirred at room temperature for 12 
h. The resulting mixture was concentrated by rotary evaporation and purified by column
chromatography with CHCl3:hexanes = 3:2 (v/v) as eluent to yield 7 as a orange solid
(880 mg, 30% for 2 steps). 1H NMR (400 MHz, CDCl3) δ 11.60 (s, 1H), 9.60 (dd, J =
2, 1.2 Hz, 1H), 9.55 (dd, J = 10.0, 1.2 Hz, 1H), 7.78 – 7.66 (m 2H); 13C NMR spectra
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of 7 is not available due to the low solubility; HRMS (m/z, MALDI-TOF, [M+H]+) 
Calcd for C11H579BrN2OS 292.9379, found 292.9391; Calcd for C11H581BrN2OS
294.9358, found 294.9448. 
Synthesis of compound 8 
A mixture of 4-methyl-N-(p-tolyl)-N-(4-(trimethylstannyl)-phenyl)aniline (2.1 
mmol), 6 (0.60 g, 1.7 mmol), and PdCl2(PPh3)2 (63 mg, 0.09 mmol) in anhydrous 
toluene (105 mL) was stirred and heated at reflux temperature under argon atmosphere 
for 2 h. After cooling to room temperature, the solvent was removed by rotary 
evaporation. The resulting mixture was extract with chloroform, washed with brine, 
dried over anhydrous MgSO4, filtered, and then concentrated under reduced pressure. 
The crude product was purified by column chromatography with CHCl3:hexanes = 1:1 
(v/v) as eluent to yield 10 as a blue solid (0.70 g, 75%). 1H NMR (400 MHz, CDCl3) δ 
10.81 (s, 1H), 9.51 (s, 1H), 9.02 (s, 1H), 8.05 (d, J = 8.8 Hz, 2H), 7.19 (d, J = 8.8 Hz, 
2H), 7.16 – 7.10 (m, 8H), 2.35 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 188.93, 153.87, 
153.67, 149.69, 144.51, 136.99, 133.72, 132.26, 130.43, 130.12, 128.23, 126.12, 
125.57, 123.28, 123.00, 120.85, 20.91. 
Synthesis of compound 9 
A mixture of (4-(di-p-tolylamino)phenyl)boronic acid (1.8 mmol), 7 (440 mg, 1.5 
mmol), potassium carbonate (622 mg, 4.5 mmol) and Pd(PPh3)4 (173 mg, 0.15 mmol) 
in anhydrous toluene (15 mL) and nitrogen-bubbled distilled water (2.5 mL) was stirred 
and heated at reflux temperature under argon atmosphere for 12 h. After cooling to 
room temperature, the solvent was removed by rotary evaporation. The resulting 
mixture was extract with chloroform, washed with brine, dried over anhydrous MgSO4, 
filtered, and then concentrated under reduced pressure. The crude product was purified 
by column chromatography with CH2Cl2:hexanes = 1:1 (v/v) as eluent to yield 9 as a 
dark blue solid (490 mg, 67%). 1H NMR (400 MHz, CD2Cl2) δ 11.60 (s, 1H), 9.62 (d, 
J = 9.2 Hz, 1H), 8.26 (d, J = 8.8 Hz, 1H), 7.75 – 7.71 (m, 1H), 7.52-7.47 (m, 3H), 7.19 
– 7.14 (m, 10H), 2.35 (s, 6H); 13C NMR (100 MHz, CD2Cl2) δ 191.80, 191.71, 155.85,
152.39, 149.79, 145.16, 140.48, 134.53, 134.06, 133.00, 131.97, 130.70, 128.63,
128.01, 126.99, 126.48, 126.28, 120.38, 117.54, 21.17; HRMS (m/z, MALDI-TOF,
[M]+) Calcd for C31H23N3OS 485.1562, found 485.1577.
Synthesis of DCPNT 
A mixture of 8 (0.70 g, 1.3 mmol), malononitrile (0.34 g, 5.2 mmol) in anhydrous 
CH2Cl2 (65 mL) was added five drops of trimethylamine and then stirred at room 
temperature for 20 min. The resulting mixture was poured into methanol and then 
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filtered. The collecting solid was purified by column chromatography with CHCl3 as 
eluent to yield DCPNT as a blue solid (0.36 g, 47%). M.p. 297 oC (DSC); 1H NMR 
(400 MHz, CDCl3) δ 10.06 (s, 1H), 8.97 (s, 1H), 8.91 (s, 1H), 8.07 (d, J = 8.8 Hz, 2H), 
7.22 – 7.05 (m, 10H), 2.36 (s, 6H); HRMS (m/z, FAB+) Calcd for C34H21N7S2 591.1300, 
found 591.1285. 
Synthesis of DCPNT 
A mixture of 9 (490 mg, 1 mmol), malononitrile (120 mg, 1.8 mmol) in anhydrous 
CH2Cl2 (20 mL) was added five drops of trimethylamine and then stirred at room 
temperature for 20 min. The resulting mixture was poured into methanol and then 
filtered to yield DCPNBT as a brown solid (460 mg, 86%). 1H NMR (400 MHz, CDCl3) 
δ 8.88 (s, 1H), 8.30 (d, J = 9.2 Hz, 1H), 8.05 (d, J = 8.8 Hz, 1H), 7.73 – 7.67 (m, 1H), 
7.53-7.50 (m, 3H), 7.20 – 7.14 (m, 10H), 2.36 (s, 6H); 1H NMR (400 MHz, CDCl3) δ 
8.88 (s, 1H), 8.30 (d, J = 9.2 Hz, 1H), 8.05 (d, J = 8.8 Hz, 1H), 7.73 – 7.67 (m, 1H), 
7.53-7.50 (m, 3H), 7.20 – 7.14 (m, 10H), 2.36 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 
154.39, 151.36, 150.26, 149.35, 144.43, 138.61, 133.92, 133.41, 132.46, 131.05, 
130.19, 129.99, 129.26, 126.61, 125.86, 124.33, 119.75, 116.45, 114.09, 112.51, 89.57, 
20.91; HRMS (m/z, ESI, [M+H]+) Calcd for C34H24N5S 534.1747, found 534.1715. 
Synthesis of intermediate 10 
A mixture of (4-(di-p-tolylamino)phenyl)boronic acid (2.03 g, 6.4 mmol), 1 (3.22 g, 8 
mmol), Pd(PPh3)4 (280 mg, 0.24 mmol), and potassium carbonate (3.31 g , 24 mmol) 
in anhydrous toluene (450 mL) and nitrogen-bubbled distilled water (15 mL) was 
stirred and heated at reflux temperature under argon atmosphere for 12 h. After cooling 
to room temperature, the solvent was removed by rotary evaporation. The resulting 
mixture was extract with chloroform, washed with brine, dried over anhydrous MgSO4, 
filtered, and then concentrated under reduced pressure. The crude product was purified 
by column chromatography with CHCl3:hexanes = 1:1 (v/v) to afford intermediate 3 
directly used into next step. 
Synthesis of compound 11 
A mixture of (4-(di-p-tolylamino)phenyl)boronic acid (1.38g, 4.4mmol), 2 (1.00 g, 2.9 
mmol), Pd(PPh3)4 (168 mg, 0.14 mmol), and potassium carbonate (2 g , 14.5 mmol) in 
anhydrous toluene (30 mL) and nitrogen-bubbled distilled water (7.5 mL) was stirred 
and heated at reflux temperature under argon atmosphere for 12 h. After cooling to 
room temperature, the solvent was removed by rotary evaporation. The resulting 
mixture was extract with chloroform, washed with brine, dried over anhydrous MgSO4, 
filtered, and then concentrated under reduced pressure. The crude product was purified 
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by column chromatography with CH2Cl2:hexanes = 3:7 (v/v) to afford 11 as purple solid 
(825 mg, 53%).1H NMR (400 MHz, CD2Cl2) δ 8.44 (d, J = 9.2 Hz, 1H), 8.13 (d, J = 
8.8 Hz, 1H), 7.59 – 7.55 (m, 1H), 7.45 – 7.38 (m, 3H), 7.20-7.12 (m, 10H), 2.35 (s, 6H); 
13C NMR (100 MHz, CDCl3) δ 151.36, 151.29, 148.71, 145.06, 135.66, 133.59, 133.32, 
132.67, 132.22, 131.36, 130.30, 128.90, 128.45, 128.04, 127.80, 127.62, 126.68, 
125.75, 120.78, 110.97, 21.10; HRMS (m/z, MALDI-TOF, [M]+) Calcd for 
C30H2279BrN3S 535.0712, found 535.0738; Calcd for C30H2281BrN3S 537.0695, found 
537.0832. 
Synthesis of CPNT 
A mixture of intermediate 10 (1.74 g, 3 mmol), copper(I) cyanide (0.8 g, 9 mmol) 
in 1-methyl-2-pyrrolidone (30 mL) was stirred and heated to 190 oC by microwave 
reactor for 2 h. After cooling to room temperature, the resulting mixture was stirred 
with ferric chloride hydrochloric acid at 60 oC for 30 min, extracted with chloroform, 
washed with brine, dried over anhydrous MgSO4, filtered, and then concentrated under 
reduced pressure. The crude product was purified by column chromatography with 
CHCl3:hexanes = 1:1 (v/v) as eluent to yield CPNT as a purple solid (0.78 g, 48%). 
M.p. 278 oC (DSC); 1H NMR (400 MHz, CDCl3) δ 9.33 (s, 1H), 8.94 (s, 1H), 8.02 (d,
J = 7.8 Hz, 2H), 7.19 – 7.11 (m, 10H), 2.36 (s, 6H); 13C NMR (100 MHz, CDCl3) δ
153.44, 153.18, 152.54, 152.29, 149.76, 144.42, 137.15, 134.44, 133.79, 130.40,
130.13, 129.06, 127.90, 125.60, 122.78, 122.61, 120.70, 115.44, 103.74, 20.92; HRMS
(m/z, ESI, [M+H]+) Calcd for C31H21N6S2 541.1264, found 541.1228.
Synthesis of CPNBT 
A mixture of 1 (825 mg, 1.54 mmol), copper(I) cyanide (413 mg, 4.61 mmol) in 1-
methyl-2-pyrrolidone (15 mL) was stirred and heated to 190 oC by microwave reactor 
for 2 h. After cooling to room temperature, the resulting mixture was stirred with ferric 
chloride in hydrochloric acid at 60 oC for 30 min, extracted with chloroform, washed 
with brine, dried over anhydrous MgSO4, filtered, and then concentrated under reduced 
pressure. The crude product was purified by column chromatography with 
CHCl3:hexanes = 2:1 (v/v) as eluent to yield CPNBT as a purple solid (480 mg, 65%). 
1H NMR (400 MHz, CDCl3) δ 8.43 (d, J = 8.4 Hz, 1H), 8.26 (d, J = 9.2 Hz, 1H), 7.73 
– 7.69 (m, 1H), 7.51 – 7.48 (m, 3H), 7.20 – 7.14 (m, 10H), 2.35 (s, 6H); 13C NMR (100
MHz, CDCl3) δ 152.62, 151.23, 149.37, 144.43, 138.23, 137.11, 133.91, 132.31, 130.74,
130.37, 130.18, 128.58, 126.76, 126.27, 125.84, 119.79, 115.80, 97.43, 20.91; HRMS
(m/z, MALDI-TOF, [M]+) Calcd for C31H22N4S 482.1560, found 482.1581.
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Figure S3. 1H NMR spectra of CPNT. 
Figure S4. 13C NMR spectra of CPNT. 
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Figure S5. 1H NMR spectra of 6. 
Figure S6. 13C NMR spectra of 6. 
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Figure S7. 1H NMR spectra of 7. 
 
 
Figure S8. 1H NMR spectra of 8. 
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Figure S9. 1H NMR spectra of 9. 
Figure S10. 13C NMR spectra of 9. 
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Figure S11. 1H NMR spectra of 10. 
 
Figure S12. 13C NMR spectra of 10. 
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Figure S13. 13C NMR spectra of DCPNT. 
Figure S14. 13C NMR spectra of DCPNT. 
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Figure S15. 1H NMR spectra of DCPNBT. 
 
Figure S16. 13C NMR spectra of DCPNBT. 
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Figure S17. 1H NMR spectra of 11. 
Figure S18. 13C NMR spectra of 11. 
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Figure S19. 1H NMR spectra of CPNBT. 
Figure S20. 13C NMR spectra of CPNBT. 
